In Treatment

VIDEOS

2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포...

For the 2025 Case Based Panel Discussions, a panel of oncologists consisting of Dr. Isabel Preeshagul, Dr. Deborah Doroshow and Dr. Christine Garcia...

The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by...

The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which...

Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente...

ARTICLES

As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26...

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...

Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...

COMMUNITY FORUM

Our 4-video series, 2025 HPV Advances Patient Education Program is available free online. We want to thank Merck for sponsoring this expert-mediated...
Our 2025 Spanish Targeted Therapies in Lung Cancer Patient Forum LIVE Webinar is coming up on Saturday, August 9, 2025 . Patients and caregivers can...
A special thank you goes out to our sponsors Exelixis and Janssen for helping make the 2024-2025 Patient Education Ambassadors Program possible! All...
A special thank you goes out to our sponsors Genentech and AstraZeneca for helping make the 2025 Case-Based Panel Discussions possible!
A special thank you goes out to our sponsor Bristol-Myers Squibb for helping make the 2025 East Asian Lung Cancer Video Library possible!

Recent Comments

Hi Hopish hope,  Welcome to…
Comment By JanineT GRACE … on May 14, 2025 10:48 am
colon cancer and HIV
Comment By JanineT GRACE … on May 14, 2025 10:48 am
Thank you for sharing
Comment By LeviDrake on Apr 2, 2025 11:14 pm
Hi bluesun,I don't know of…
Comment By JanineT GRACE … on Mar 24, 2025 1:06 pm

February is GallBladder and Bile Duct Cancer Awareness Month

Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder.  Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the bile ducts.  Help us to bring awareness to these rare cancers during the month of February.  Start talking and raise awareness to Gallbladder and Bile Duct Cancer Awareness

Operations Director for GRACE. Have worked with cancerGRACE.org since July 2009.  Became involved as a caregiver to my best friend, and quickly came to see that GRACE is filling a need in the area of cancer education. 

East Asian Lung Cancer Video Llibrary 2025

Video

2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 

2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포 폐암 환자를 위한 표적 치료에 대해 논의합니다.

What is the AVO treatment for Chronic Lymphocytic Leukemia (CLL)? Acalabrutinib, Venetoclax, Obinutuzumab for High-Risk Patients

Article

The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.

Survivors Month/Glad to be Here

June is National Cancer Survivors Month.  As with many terms used in cancer, not everyone who has incurable cancer sees themselves as a survivor if they aren't going to survive cancer, and some people are happy to take on the mantle of "survivor", no matter the prognosis.

 

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.
Subscribe to In Treatment